
T-Minic Syrup 60ml
In Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
Similar Medicine Of
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to
This formula is generally prescribed to children to treat cough, runny nose, sneezing, body ache, sore throat, watery eyes, and fever These symptoms are usually related to hay fever, common cold, and other respiratory conditions
This formulation has been prepared from the combination of Chlorpheniramine maleate and Phenylephrine. Chlorpheniramine inhibits histamine, which relieves allergy symptoms such as sneezing and itching. Chlorpheniramine is an antihistamine that stops the body from making histamine during an allergic reaction. Phenylephrine is a nasal decongestant that makes breathing easier by treating swelling and congestion by contracting the blood vessels present in the nasal passages.
- Follow the instructions provided by your doctor
- Must follow your prescription
- If you have any allergy to the content of medicine, inform your doctor
- If you have any medical conditions inform your doctor
- This medicine is used to provide relief from the symptoms of cold, itching, and sneezing, of the throat and nose
- It also makes breathing easier
- Pale skin
- Restlessness
- Dry nose
- Vomiting
- Rash
- Tremor
- Palpitations
Health And Lifestyle
- MAO Inhibitors (Phenelzine),
- Antidepressants (Citalopram)
- N/A

Common cold and flu is a communicable disease which occurs due to different type of viruses. common symptoms are sore thorat, sneezing and cough.
Safety Advice For
- High risk
- Moderate risk
- Safe
Use with caution; tests for liver function may need to be monitored often.
Refrain from consuming alcohol while using this medication.
If impacted, avoid driving since it may cause sleepiness or dizziness.
In patients with impaired renal function, use with caution.
Written By
Ashwani Singh
Master in Pharmacy
Content Updated on
Thursday, 19 June, 2025













